Insight Genetics Developing RT-PCR-Based ALK Mutation Tests Under St. Jude License
December 23, 2010
Insight Genetics Developing RT-PCR-Based ALK Mutation Tests Under St. Jude License
Insight is developing the tests using TaqMan probes on Life Technologies' ABI 7500 Fast Dx real-time PCR system to help physicians monitor cancer patients for mutations and upregulation in the ALK gene in order to make more effective treatment decisions.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Insight Genetics Wins $1.5M Grant to Begin Clinical Testing for ALK Mutation CDx on Qiagen Platform
October 11, 2012 / PCR Insider - Life Technologies Licenses Stem Cell Assay Tech from Harvard
March 4, 2013 / GenomeWeb Daily News - Qiagen Expands Companion Dx Portfolio with Three Licensing Deals; Exceeds 2012 QiaSymphony Placement Target
January 7, 2013 / GenomeWeb Daily News - VelaDx Licenses Swift Bio's Primer Technology for PCR-based Dx
December 3, 2012 / GenomeWeb Daily News - Swedish Team, Life Tech Develop Method for qPCR Analysis of Proteins, RNA, DNA in Single Cells
October 18, 2012 / PCR Insider